Delivery Order SPE2DB24D2010-SPE2DB25FZVR5
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The $5,570.89 contract, which has an ultimate completion date of April 8, 2024, does not have a set-aside designation. AmerisourceBergen Drug Corp, the prime contractor, is also the holder of a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to provide a wide...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml. The contract has a ceiling value of $10,190.52 and a period of performance through September 12, 2024. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $2,954.06 and a period of performance through March 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $5,102.97, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. The award, valued at $51,508.23, has an ultimate completion date of April 15, 2024. This order is being issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31,...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $2,612.34 and a period of performance through March 18, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that DLA has with Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical...
This is a $2,767.51 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is...
The U.S. Defense Logistics Agency (DLA) awarded a $10,449.36 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. This contract has an ultimate completion date of August 5, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $9,859.73 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. This delivery order contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC...